Connor, Clark & Lunn Investment Management »

Atyr Pharma shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Atyr Pharma (ATYR) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $15k 21k 0.72

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Agnico (AEM)
Shopify Cl A Sub Vtg Shs (SHOP)
Cibc Cad (CM)
Toronto Dominion Bk Ont Com New (TD)
NVIDIA Corporation (NVDA)
Invesco Exch Traded Fd Tr Ii Purbta Msci Us (PBUS)
Microsoft Corporation (MSFT)
Bk Nova Cad (BNS)
Apple (AAPL)
Tc Energy Corp (TRP)
Suncor Energy (SU)
Celestica (CLS)
Amazon (AMZN)
Enbridge (ENB)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Atyr Pharma

FMR
Federated Investors
BlackRock
Vanguard Group
UBS Group
State Street Corporation
Geode Capital Management
Affinity Asset Advisors
Millennium Management
Susquehanna International
Rosalind Advisors
Artia Global Partners
Jane Street
Citadel Advisors
GSA Capital Partners

View all funds holding Atyr Pharma